UNIKAALNE KAITSTUD INTELLEKTUAALNE OMAND

No. / date of issue Name AUTHORS Note
1 CH 659586 Arzneimittel aus dem Thymus und Verfahren zu dessen Herstellung. (A drug from the thymus and a method for its preparation) Morozov V.G. Khavinson V.Kh. Switzerland, February 13, 1987
2 DE 3421789 Arzneimittel auf der Basis einer Thymusfraktion und Verfahren zu dessen Herstellung. (A drug from the thymus and a method for its preparation) Morozov V.G. Khavinson V.Kh. France, February 24, 1989
3 Fr 2583982 Produit medicamenteux obtenu a partir du thymus et son procede d’obtention. (A drug from the thymus and a method for its preparation) Morozov V.G. Khavinson V.Kh. France, February 24, 1989
4 JP 1625201 Process for Production of Thymus Gland Preparation. (Method of obtaining a drug from the thymus) Morozov V.G. Khavinson V.Kh. Japan, 11/18/1991
5 US 5,070,076 Thymus-Gland preparation and method for producing same. (A preparation from the thymus and a method of obtaining it) Morozov V.G. Khavinson V.Kh. USA, 03.12.1991
8 BY 140 Immunostimulating agent “Timogen”. Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Republic of Belarus, 26.10.1993
9 CA 1,330,300 Pharmaceutical preparation for therapy of immunodeficient states. (Medicinal product for the treatment of immunodeficiency states) Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Canada, 21.06.1994
10 LV 5407 Imünstimulĕjošs lidzeklis “TIMOGEN”. (Immunostimulating agent “Timogen”) Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Latvia, 10.03.1994
12 UA 7130 Immunity mutiluyuchy zasib “Timogen”. (Immunostimulating agent “Timogen”) Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Ukraine, June 30, 1995
13 JP 2511159 Pharmaceutical preparation for treating immunodeficiency conditions. (Medicinal product for the treatment of immunodeficiency states) Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Japan, 06/26/1996
14 US 5,538,951 Pharmaceutical preparation for the therapy of immune deficiency conditions. (Medicinal product for the treatment of immunodeficiency states) Morozov V.G. Khavinson V.Kh. USA, 07/23/1996
15 US 5,728,680 Methods for normalizing numbers of lymphocytes. (Method for normalizing the number of lymphocytes) Morozov V.G. Khavinson V.Kh. USA, 07/23/1996
16 US 5,767,087 Pharmaceutical preparation for the therapy of immune deficiency conditions. (Medicinal product for the treatment of immunodeficiency states) Morozov V.G. Khavinson V.Kh. USA, 06/16/1998
18 US 5,789,384 Pharmaceutical dipeptide compositions and methods of use thereof. (Pharmaceutical composition of dipeptide and methods of its use) Khavinson V.Kh. Gray S.V. Morozov V.G. USA, 04.08.1998
19 US 5,807,830 Method for treatment of purulent inflammatory diseases. (A method for treating purulent-inflammatory diseases) Morozov V.G. Khavinson V.Kh. USA, 09/15/1998
20 US 5,811,399 Pharmaceutical dipeptide formulations and methods of use thereof: immunodepressants. (Pharmaceutical composition of the dipeptide and methods of its use: immunosuppressants) Khavinson V.Kh. Morozov V.G. USA, 09.22.1998
21 US 5,814,611 Pharmaceutical for the therapy of immune deficiency conditions. (Medicinal product for the treatment of immunodeficiency states) Morozov V.G. Khavinson V.Kh. USA, 09.29.1998
22 US 6,066,622 Immunomodulating peptides and methods of use. (Immunomodulating peptides and methods of their use) Green L. Sinakevich N.V. Ivanov V.T. Mikhailova I.I. Vaskovsky BV Mikhaltsov A.N. Khavinson V.Kh. Morozov V.G. USA, May 23, 2000
23 US 6,100,380 Immunomodulating peptides and methods of use. (Immunomodulating peptides and methods of their use) Green L. Sinakevich N.V. Ivanov V.T. Mikhailova I.I. Vaskovsky BV Mikhaltsov A.N. Morozov V.G. Khavinson V.Kh. USA, August 8, 2000
24 US 6,136,788 Pharmaceutical preparation for the therapy of immune deficiency conditions. (Medicinal product for the treatment of immunodeficiency states) Morozov V.G. Khavinson V.Kh. USA, October 24, 2000
25 US 6,139,862 Pharmaceutical dipeptide compositions and methods of use thereof. (Pharmaceutical composition of dipeptide and methods of its use) Khavinson V.Kh. Gray S.V. Morozov V.G. USA, October 31, 2000
28 CH 692 477 Zusammensetzung zur Stimulation von Wiederherstellungsvorgängen, enthaltend L-Lysil-L-Glutaminsäure. (Use of a dipeptide to stimulate reparative processes) Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. Switzerland, July 15, 2002
29 EP 1 224 212 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof. (Tetrapeptide stimulating the functional activity of neurons, a pharmacological agent based on it and the method of its use) Khavinson V.Kh. Morozov V.G. Malinin V.V. Grigoriev EI European patent 09.07.2003
31 US 6,642,201 Use of a dipeptide for stimulating repair processes. (Use of a dipeptide to stimulate reparative processes) Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. USA, 04.11.2003
32 US 6,727,227 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. USA, 27.04.2004
33 AU 769847 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. USA, 27.04.2004
34 US 6,777,195 Phharmaceutical dipeptide compounds and methods of use thereof: immunostimulants. (Pharmaceutical dipeptide compositions and methods of their use: immunostimulants) Kozhemyakin A.L. Sinakevich N.V. Gray S.V. Rakhilov A.M. Morozov V.G. Khavinson V.Kh. USA, August 17, 2004
35 EP 1 325 026 Tetrapeptide stimulating the functional activity of hepatocytes and its therapeutic use. (Tetrapeptide, stimulating the functional activity of hepatocytes and the way it is used.) Khavinson V.Kh. European patent 18.08.2004
36 EP 1 353 939 Tetrapeptide regulating prostate functions and its compositions and uses. (Tetrapeptide, regulating the functions of the prostate gland, a pharmacological agent based on it and the way it is used) Khavinson V.Kh. Malinin V.V. Grigoriev EI European patent 25.08.2004
37 DK 175381 Farmaceutisk prӕparat til behandling af immundefekttilstande. (Medicinal product for the treatment of immunodeficiency states) Yakovlev G.M. Morozov V.G. Khavinson V.Kh. Deigin V.I. Korotkov A.M. Denmark, September 20, 2004
38 AU 776693 Use of a dipeptide for stimulating repair processes. (Use of a dipeptide to stimulate reparative processes) Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. Australia, 06.01.2005
39 EP 1 179 008 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. European patent 22.03.2006
40 AU 784578 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof. (Tetrapeptide stimulating the functional activity of neurons, a pharmacological agent based on it and the method of its use) Khavinson V.Kh. Morozov V.G. Malinin V.V. Grigoriev EI Australia, August 17, 2006
41 US 7,101,854 Tetrapeptide stimulating the functional activity of hepatocytes, the pharmacological substance on its basis and the method of its application. (Tetrapeptide, stimulating the functional activity of hepatocytes, a pharmacological agent based on it and the way it is used) Khavinson V.Kh. USA, 05.09.2006
42 JP 3902406 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. Japan, January 12, 2007
43 US 7,189,701 Tetrapeptide stimulating functional activity of neurons, pharmacological agent based thereon and method of use thereof. (Tetrapeptide stimulating the functional activity of neurons, a pharmacological agent based on it and the method of its use) Khavinson V.Kh. Orozov V.G. Malinin V.V. Grigoriev EI USA, 13.03.2007
44 LV 13462 Cukuralīmeni asinīs regulējošs tetrapeptīds cukurslimības ārstēšanai. (Tetrapeptide, regulating glucose level in diabetes mellitus) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. Latvia, February 20, 2007
45 CA 2,373,128 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. Canada, 13.03.2007
46 LT 5421 Tetrapeptidas, reguliuojantis kraujo gliukozės lygi, sergant cukriniu diabetu. (Tetrapeptide, regulating glucose level in diabetes mellitus) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. Lithuania, 25.05.2007
47 EA 008541 Tetrapeptide, regulating the level of glucose in the blood in diabetes mellitus. Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. Eurasia, June 29, 2007
48 IL 146432 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application. (Tetrapeptide, which has geroprotective activity, a pharmacological agent based on it and the method of its application) Khavinson V.Kh. Israel, 04.09.2007
49 IL 140412 L-LYS-L-GLU dipeptides for pharmaceutical preparations. (Dipeptides L-LYS-L-GLU for pharmaceutical preparations). Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. Israel, September 17, 2007
50 EP 1 758 922 Peptide substance restoring function of respiratory organs. (Peptide compound restoring respiratory function). Khavinson V.Kh. Ryzhak G.A. Grigoriev EI Ryadnova I.Yu. European patent 13.02.2008
51 EP 1 758 923 Peptide substance restoring myocardium function. (Peptide compound restoring myocardial function). Khavinson V.Kh. Ryzhak G.A. Grigoriev EI Ryadnova I.Yu. European patent 13.02.2008
52 EA 010156 A peptide that stimulates the regeneration of liver tissue, a pharmaceutical composition based on it and a method for its application. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, June 30, 2008
53 EA 010157 A peptide stimulating the regeneration of neurons of the central nervous system, a pharmaceutical composition based on it, and the method of its application. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, June 30, 2008
54 EA 010158 A peptide that increases the resistance of capillaries, a pharmaceutical composition based on it, and the method of its use. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, June 30, 2008
55 EA 010573 Hepatoprotective agent and method of its preparation. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
56 EA 010574 A peptide that normalizes metabolism in bone and cartilaginous tissues, a pharmaceutical composition based on it and the way it is used. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
57 EA 010575 A peptide having an immuno-protective effect, a pharmaceutical composition based on it, and a method for its use. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
58 EA 010720 A method of obtaining an agent for maintenance therapy having tissue-specific activity, and a means obtained by this method (variants). Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
59 EA 010722 A remedy that normalizes the tone of the bladder and the way it is produced. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
60 EA 010723 A remedy that normalizes kidney function and the way it is obtained. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
61 EA 010724 A remedy that normalizes the functions of the cartilage tissue, and the way it is produced. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
62 EA 010734 A remedy that normalizes the function of blood vessels, and the way it is produced. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
63 EA 010735 An agent that normalizes reproductive function in men, and the way it is obtained. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
64 EA 010736 An agent that normalizes the reproductive function of women, and the way it is produced. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
65 EA 010737 An agent possessing geroprotective activity, and a method for its preparation. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
66 EA 010738 A remedy that normalizes the functions of the thyroid gland, and the way it is produced. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
67 EA 010739 An agent that normalizes the function of the brain, and the way it is obtained. Khavinson V.Kh. Malinin V.V. Ryzhak G.A. Eurasia, 30.10.2008
68 EA 011092 A peptide having a stress-protective action, a pharmaceutical composition based on it, and a method of using it. Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Eurasia, 30.12.2008
69 UA 85204 Tetrapeptide, which regulates the flow of glucose in the blood with a zuccharic diabeti. (Tetrapeptide, regulating glucose level in diabetes mellitus) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. / div> Ukraine, 12.01.2009
70 US 7,491,703 Tetrapeptide regulating blood glucose level in diabetes mellitus. (Tetrapeptide, regulating glucose level in diabetes mellitus) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. USA, 17.02.2009
71 EP 2 024 388 Peptide substance stimulating regeneration of the central nervous system neurons, pharmaceutical composition on its base, and the method of its application. (Peptide stimulating the regeneration of neurons of the central nervous system, a pharmaceutical composition based on it and the way it is used.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Europe, 10/14/2009
72 EP 2 024 387 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and the method of its application. (A peptide that increases the resistance of capillaries, a pharmaceutical composition based on it, and the way it is used.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Europe, 21.10.2009
73 US 7,625,870 Peptide substance restoring respiratory organs function. (Peptide compound restoring respiratory function). Khavinson V.Kh. Ryzhak G.A. Grigoriev EI Ryadnova I.Yu. USA, 01.12.2009
74 EP 1 697 401 Tetrapeptide regulating blood glucose level in diabetes mellitus. (Tetrapeptide, regulating glucose level in diabetes mellitus) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. Europe, 01/06/2010
75 US 7,662,789 Peptide substance restoring myocardium function. (Peptide compound restoring myocardial function.) Khavinson V.Kh. Ryzhak G.A. Grigoriev EI Ryadnova I.Yu. USA, February 16, 2010
76 JP 4489946 Use of a dipeptide for stimulating repair processes. (Use of a dipeptide to stimulate reparative processes) Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. Japan, 09/04/2010
77 UA 91135 A peptide, which is an iMunogeroprotective dyu, is a pharmaceutical composition based on the yogo basis i spisibe zastosuvannya. (A peptide having an immuno-protective effect, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Ukraine, June 25, 2010
78 UA 91136 The peptide stimulates the regeneration of the neurons in the central nervous system, the pharmaceutical composition of the yogo basis i spisibe zastosuvannya. (Peptide stimulating the regeneration of neurons of the central nervous system, a pharmaceutical composition based on it and the way it is used.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Ukraine, June 25, 2010
79 UA 91137 The peptide, the resistance of the capsules, the pharmaceutical composition on the yogo basis i sposib її zastosuvannya. (A peptide that increases the resistance of capillaries, a pharmaceutical composition based on it, and the way it is used.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Ukraine, June 25, 2010
80 AU 2004296269 Tetrapeptide regulating blood glucose level in diabetes mellitus. (Tetrapeptide, regulating glucose level in diabetes mellitus.) Grigoriev EI Khavinson V.Kh. Ryzhak G.A. Malinin V.V. Australia, 16.09.2010
81 UA 92387 A peptide, which is stress resistant to dyu, a pharmaceutical composition on yogo basis i sposib її zastosuvannya. (A peptide having a stress-protective action, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Ukraine, October 25, 2010
82 US 7,851,449 Peptide, pharmaceutical composition, and a method of treating microcirculation disorders. (Peptide, pharmaceutical composition, and method of treating microcirculatory disorders.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. USA, December 14, 2010
83 CA 2.425.445 Tetrapeptide stimulating the functional activity of hepatocytes, the pharmacological substance on its basis and the method of its application. (Tetrapeptide, stimulating the functional activity of hepatocytes and the way it is used.) Khavinson V.Kh. Canada, 01/18/2011
84 JP 4668497 Tetrapeptide stimulating functional activity of neurons, pharmacological agent based thereon and method of use thereof. (Tetrapeptide stimulating the functional activity of neurons, a pharmacological agent based on it and the method of its use) Khavinson V.Kh. Morozov V.G. Malinin V.V. Grigoriev EI Japan, 13.04.2011
85 IN 247551 Tetrapeptide lisyl-glutamyl-aspartyl-tryptophane amide. (Tetrapeptide lysyl-glutamyl-aspartyl-tryptophan amide.) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. India, 19/04/2011
86 EP 2 032 595 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application. (A peptide having an immuno-protective effect, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Europe, 06.22.2011
87 UA 62779 Sposib likuvannya prinnovnoi vidkritokutovoy glaucomi. (Method of treatment of primary open-angle glaucoma.) Panchenko M.V. Khavinson V.Kh. Ryzhak G.A. Panchenko OM Samofalova M.M. Alekseenko K.A. Yakubovich N.V. Ukraine, 12.09.2011
88 US 8,057,810 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application. (A peptide having an immuno-protective effect, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. USA, 11/15/2011
89 CA 2,547,873 Tetrapeptide regulating blood glucose level in diabetes mellitus. (Tetrapeptide, regulating glucose level in diabetes mellitus.) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. Canada, 11/22/2011
90 US 8,071,556 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application. (A peptide having a stress-protective action, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. USA, 06.12.2011
91 KR 10-1106609 Tetrapeptide regulating blood glucose level in diabetes mellitus. (Tetrapeptide, regulating glucose level in diabetes mellitus.) Khavinson V.Kh. Malinin V.V. Grigoriev EI Ryzhak G.A. South Korea, 10.01.2012
92 CA 2,335,362 Use of a dipeptide for stimulating repair processes. (Use of a dipeptide to stimulate reparative processes) Khavinson V.Kh. Morozov V.G. Malinin V.V. Gray S.V. South Korea, 10.01.2012
93 IL 194346 Tripeptide having a stimulating effect on the regeneration of neurons and pharmaceutical compositions. (Tripeptide stimulating the regeneration of neurons, and the pharmaceutical compositions that contain it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Israel, 04/01/2013
94 KR 10-1289220 Peptide substance stimulating regeneration of the central nervous system neurons, pharmaceutical composition on its base, and the method of its application. (Peptide stimulating the regeneration of neurons of the central nervous system, a pharmaceutical composition based on it and the way it is used.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. South Korea, 07/17/2013
95 US 8,524,674 The method of improving the conditioned reflex habit, the muscle tonus, or the motion of the patient after suffering trauma to the brain cortex. (A way to improve the conditioned reflex skill, increase muscle tone or coordinate movements in patients after trauma to the cerebral cortex.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. USA, 09/03/2013
96 UA 104981 Peptide pharmaceutical composition, on the basis of gastroduodenal swallowing, yaki wiklikayutsya Helicobacter pylori, i spisib yogo vichoristani. (Peptide pharmaceutical composition, a drug on its basis for the treatment of gastroduodenal diseases caused by Helicobacter pylori, and the way it is used.) Khavinson V.Kh. Kvetnoy I.M. Polyakova V.O. Ryzhak G.A. Kozlov L.V. Ukraine, March 25, 2014
97 KR 10-1382947 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application. (A peptide having an immuno-protective effect, a pharmaceutical composition based on it, and a method of using it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. South Korea, 04/01/2014
98 IL 194500 Capable of enhancing. (A peptide that increases the resistance of capillaries and a pharmaceutical composition based on it.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Israel, 05/01/2014
99 IL 194499 Peptide glutamyl-aspartyl-proline, pharmaceutical compositions containing the peptide and uses of the peptide. (Glutamyl-aspartyl-proline peptide, pharmaceutical compositions comprising a peptide and the use of this peptide.) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Israel, 01/31/2015
100 EA 021849 The use of a peptide pharmaceutical composition as an agent for the treatment of gastroduodenal diseases caused by Helicobacter pylori. Khavinson V.Kh. Kvetnoy I.M. Polyakova V.O. Ryzhak G.A. Kozlov L.V. Eurasia, 09.30.2015
101 EP 2 667 887 Pharmaceutical composition with the peptide Glu-Asp-Gly and use for treating Helicobacter pylori inducedgastroduodenal diseases. (Pharmaceutical composition based on the Glu-Asp-Gly peptide and its use for the treatment of gastroduodenal diseases caused by Helicobacter pylori) Khavinson V.Kh. Kvetnoy I.M. Polyakova V.O. Ryzhak G.A. Kozlov L.V. Europe, 12/16/2015
102 IL 194344 H-GLU-ASP-GLY-OH. Pharmaceutical composition. (A pharmaceutical composition having a stress protective action comprising a peptide H-GLU-ASP-GLY-OH) Khavinson V.Kh. Grigoriev EI Malinin V.V. Ryzhak G.A. Israel, July 22, 2016